Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Graphic for the Veterans Crisis Line. It reads Veterans Cris Lins 1 800 273 8255 press 1
 

Office of Public and Intergovernmental Affairs


VA Expands Hepatitis C Drug Treatment

March 9, 2016, 03:48:00 PM

Printable Version


 

VA Expands Hepatitis C Drug Treatment

Expanded funding now allows VA to provide increased drug therapy at VA facilities nationwide                                                            

WASHINGTON – The Department of Veterans Affairs (VA) today announced that it is now able to fund care for all Veterans with hepatitis C for Fiscal Year 2016 regardless of the stage of the patient’s liver disease. The move follows increased funding from Congress along with reduced drug prices.

 “We’re honored to be able to expand treatment for Veterans who are afflicted with hepatitis C,” says VA Under Secretary for Health Dr. David Shulkin.  “To manage limited resources previously, we established treatment priority for the sickest patients.  Additionally, if Veterans are currently waiting on an appointment for community care through the Choice Program, they can now turn to their local VA facility for this treatment or can elect to continue to receive treatment through the Choice Program.”

VA has long led the country in screening for and treating hepatitis C. VA has treated over 76,000 Veterans infected with hepatitis C and approximately 60,000 have been cured. In addition, since the beginning of 2014, more than 42,000 patients have been treated with the new highly effective antivirals.  In fiscal year 2015, VA allocated $696 million for new hepatitis C drugs (17 percent of the VA’s total pharmacy budget) and in fiscal year 2016, VA anticipates spending approximately $1 billion on hepatitis C drugs. VA expects that with the expansion, many more Veterans will be started on hepatitis C treatment every week this fiscal year. 

In addition to furnishing clinical care to Veterans with hepatitis C, VA Research continues to expand the knowledge base regarding the disease through scientific studies focused on effective care, screening, and healthcare delivery including to female Veterans and Veterans with complicated medical conditions in addition to hepatitis C. 

For additional information on Hepatitis C treatments Veterans can log onto http://www.hepatitis.va.gov/patient/hcv/index.asp.

 

# # #



People wishing to receive e-mail from VA with the latest news releases and updated fact sheets can subscribe to the
VA Office of Public Affairs Distribution List.

Back to News Releases Index



Search VA News Releases

(mm/dd/yyyy)

(mm/dd/yyyy)